What Researchers Did
Researchers conducted a review to explore current knowledge on tumour interstitial pressure and methods to reduce it.
What They Found
They found that elevated tumour pressure significantly affects the efficacy of cancer treatment by causing heterogeneous drug distribution and hypoxia, and is associated with increased metastatic potential in some tumours. Various pharmacologic, biologic, and physical agents, including antiangiogenic therapy, vasodilatory agents, and irradiation, have been shown to reduce tumour pressure, potentially enhancing the uptake and distribution of many therapies.
What This Means for Canadian Patients
Understanding how to reduce tumour pressure could lead to more effective cancer treatments for Canadian patients by improving drug delivery and overcoming resistance. This research may pave the way for new therapeutic strategies to enhance the efficacy of existing therapies.
Canadian Relevance
This review article does not have a direct Canadian connection.
Study Limitations
As a review, this study synthesizes existing literature but does not present new experimental data or clinical trial results.